The companies include drugmakers Teva, Mallinckrodt, Johnson & Johnson and Amneal Pharmaceuticals and drug distributors AmerisourceBergen and McKesson.
Federal prosecutors in the Eastern District of New York are investigating whether the companies violated the federal Controlled Substances Act by intentionally selling excessive amounts of opioids. The Controlled Substances Act requires companies to closely monitor commonly abused drugs and report suspicious orders.
Prosecutors are expected to subpoena more companies in the coming months, according to the Journal.
Drug companies have denied responsibility for the opioid crisis, saying they followed laws related to prescription painkiller manufacturing and distributing.
At least 400,000 people have died in the U.S. from overdoses of legal and illegal opioids since 1999, according to federal data cited by the Journal.
Read the full article here.
More articles on pharmacy:
Novartis pays $9.7B to acquire Medicines Co.
Drug importation plan will be released ‘soon,’ Trump tweets
From data analytics to biosimilars — How 5 pharmacy leaders are tackling drug pricing
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
